Prediction of pEC50(M) and molecular docking study for the selective inhibition of arachidonate 5-lipoxygenase

Arachidonate 5-lipoxygenase (ALOX5) is considered a prime target for drug discovery in the area of liver fibrosis, rheumatoid arthritis, atherosclerosis, cancer and asthma. To date, the lead rate in the discovery of drugs that inhibit ALOX5 for the treatment of the above diseases is not satisfactory...

Full description

Bibliographic Details
Main Authors: N. R. Das, P. G. R. Achary
Format: Article
Language:English
Published: National Academy of Sciences of Ukraine, Palladin Institute of Biochemistry 2021-12-01
Series:The Ukrainian Biochemical Journal
Subjects:
Online Access:http://ukrbiochemjournal.org/wp-content/uploads/2021/12/Das_6_21.pdf
_version_ 1797668863456837632
author N. R. Das
P. G. R. Achary
author_facet N. R. Das
P. G. R. Achary
author_sort N. R. Das
collection DOAJ
description Arachidonate 5-lipoxygenase (ALOX5) is considered a prime target for drug discovery in the area of liver fibrosis, rheumatoid arthritis, atherosclerosis, cancer and asthma. To date, the lead rate in the discovery of drugs that inhibit ALOX5 for the treatment of the above diseases is not satisfactory. So, the development of powerful and effective ALOX5-targeted drugs is desired. In this regard, Quantitative Structure-Activity Relationship (QSAR) and molecular docking can have a major role in screening and designing drugs. In this work, 3D-QSAR models were proposed, which were built using the techniques like Multiple Linear Regression (MLR), and Partial Least Squares (PLS) for the pEC50(M) taking a diverse dataset of 112 molecules. The technique of the ‘Index of Ideality of Correlation (IIC)’ was also investigated to generate an optimal descriptor derived from the SMILES molecular structure. The effect of the number and nature of descriptors on the model were analyzed. The models can be helpful in providing better directions for the development of novel drug targets for 5-lipoxygenase. A significant improvement in the stability of the model was observed by the incorporation of the optimal descriptor. The molecular docking results showed that the ALOX5 receptor was well inhibited by the 112 ligands showing the least binding energy (-10.8 Kcal/mol). In order to validate the binding mode of the ligands docked with AutoDock Vina software, the top-scored compounds were re-docked using DockThor online docking server. The results obtained from docking suggest that the ligands with IDs 18, 20, 24, 30 and 44 are some of the potential inhibitors for ALOX5.
first_indexed 2024-03-11T20:34:42Z
format Article
id doaj.art-d12012b1861e4d6b9f185cf6b3df8207
institution Directory Open Access Journal
issn 2409-4943
2413-5003
language English
last_indexed 2024-03-11T20:34:42Z
publishDate 2021-12-01
publisher National Academy of Sciences of Ukraine, Palladin Institute of Biochemistry
record_format Article
series The Ukrainian Biochemical Journal
spelling doaj.art-d12012b1861e4d6b9f185cf6b3df82072023-10-02T07:19:13ZengNational Academy of Sciences of Ukraine, Palladin Institute of BiochemistryThe Ukrainian Biochemical Journal2409-49432413-50032021-12-0193610111810.15407/ubj93.06.101Prediction of pEC50(M) and molecular docking study for the selective inhibition of arachidonate 5-lipoxygenaseN. R. Das0https://orcid.org/0000-0003-4153-8504P. G. R. Achary1https://orcid.org/0000-0002-9631-3356Department of CSIT, Siksha ‘O’ Anusandhan deemed to be University, Bhubaneswar, Odisha, IndiaDepartment of Chemistry, Faculty of Engineering and Technology (ITER), Siksha ‘O’ Anusandhan deemed to be University, Bhubaneswar, Odisha, IndiaArachidonate 5-lipoxygenase (ALOX5) is considered a prime target for drug discovery in the area of liver fibrosis, rheumatoid arthritis, atherosclerosis, cancer and asthma. To date, the lead rate in the discovery of drugs that inhibit ALOX5 for the treatment of the above diseases is not satisfactory. So, the development of powerful and effective ALOX5-targeted drugs is desired. In this regard, Quantitative Structure-Activity Relationship (QSAR) and molecular docking can have a major role in screening and designing drugs. In this work, 3D-QSAR models were proposed, which were built using the techniques like Multiple Linear Regression (MLR), and Partial Least Squares (PLS) for the pEC50(M) taking a diverse dataset of 112 molecules. The technique of the ‘Index of Ideality of Correlation (IIC)’ was also investigated to generate an optimal descriptor derived from the SMILES molecular structure. The effect of the number and nature of descriptors on the model were analyzed. The models can be helpful in providing better directions for the development of novel drug targets for 5-lipoxygenase. A significant improvement in the stability of the model was observed by the incorporation of the optimal descriptor. The molecular docking results showed that the ALOX5 receptor was well inhibited by the 112 ligands showing the least binding energy (-10.8 Kcal/mol). In order to validate the binding mode of the ligands docked with AutoDock Vina software, the top-scored compounds were re-docked using DockThor online docking server. The results obtained from docking suggest that the ligands with IDs 18, 20, 24, 30 and 44 are some of the potential inhibitors for ALOX5.http://ukrbiochemjournal.org/wp-content/uploads/2021/12/Das_6_21.pdf5-lipoxygenasemolecular dockingqsarsmiles
spellingShingle N. R. Das
P. G. R. Achary
Prediction of pEC50(M) and molecular docking study for the selective inhibition of arachidonate 5-lipoxygenase
The Ukrainian Biochemical Journal
5-lipoxygenase
molecular docking
qsar
smiles
title Prediction of pEC50(M) and molecular docking study for the selective inhibition of arachidonate 5-lipoxygenase
title_full Prediction of pEC50(M) and molecular docking study for the selective inhibition of arachidonate 5-lipoxygenase
title_fullStr Prediction of pEC50(M) and molecular docking study for the selective inhibition of arachidonate 5-lipoxygenase
title_full_unstemmed Prediction of pEC50(M) and molecular docking study for the selective inhibition of arachidonate 5-lipoxygenase
title_short Prediction of pEC50(M) and molecular docking study for the selective inhibition of arachidonate 5-lipoxygenase
title_sort prediction of pec50 m and molecular docking study for the selective inhibition of arachidonate 5 lipoxygenase
topic 5-lipoxygenase
molecular docking
qsar
smiles
url http://ukrbiochemjournal.org/wp-content/uploads/2021/12/Das_6_21.pdf
work_keys_str_mv AT nrdas predictionofpec50mandmoleculardockingstudyfortheselectiveinhibitionofarachidonate5lipoxygenase
AT pgrachary predictionofpec50mandmoleculardockingstudyfortheselectiveinhibitionofarachidonate5lipoxygenase